Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035474 | SCV000059122 | likely benign | not specified | 2008-03-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000629075 | SCV000749988 | likely benign | Hypertrophic cardiomyopathy | 2025-01-23 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000770337 | SCV000901771 | likely benign | Cardiomyopathy | 2016-08-25 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000770337 | SCV001358506 | likely benign | Cardiomyopathy | 2018-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426550 | SCV002730683 | likely benign | Cardiovascular phenotype | 2022-05-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000629075 | SCV004842377 | likely benign | Hypertrophic cardiomyopathy | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000035474 | SCV001920355 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701645 | SCV001928724 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001701645 | SCV001957031 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004549419 | SCV004717768 | likely benign | MYBPC3-related disorder | 2020-09-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |